Tarsus to expand eye disease pipeline with up to $800 million Alkeus acquisition - Reuters
Tarsus to expand eye disease pipeline with up to $800 million Alkeus acquisition Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxQbTlMM2pBQ1Eyd01DV2xwWEl3WDRFWFdYTFNTV2dlaUFlYnV6QmgzQ0ZMOHVpUWZ1d196Z013NTUzdkNyLUEwTVdfdHdSM0t1MWZEcnZ0eVppUWhyVjFfUWVqWlhxMThHeHIyV3lQS2JYSjN0YUU3VDFCTHlGYmlRTG5FSjRweWJqLUxtOVVfbTlsSHI3dWN2VnIycXlRZ2pVcDBUZ0dTRUdBbjJPMXg2bjRTWFFNMHdJSjU4U1A5SVQ5UDFQ?oc=5" target="_blank">Tarsus to expand eye disease pipeline with up to $800 million Alkeus acquisition</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Boots has a new owner: Three ways it could affect you
The stalwart of Britain's High Street has been sold to a Canadian billionaire family. What will that mean for you?
October 9, 2026 at 11:01 PMReport highlights flaws in ADHD and autism care
There is a risk of people being over-diagnosed with ADHD and autism, an official review in England has found.
October 9, 2026 at 01:52 PMHumana surges after topping 2027 Medicare star ratings - Reuters
Humana surges after topping 2027 Medicare star ratings Reuters
October 9, 2026 at 01:33 PMMost Medicare Advantage drug plan enrollees in high-quality plans, US government says - Reuters
Most Medicare Advantage drug plan enrollees in high-quality plans, US government says Reuters
October 8, 2026 at 11:29 PMADHD and autism at risk of over-diagnosis, says government review
The review, which focuses on younger people, warned there was a risk society was moving from an era of under-diagnosis to over-diagnosis.
October 8, 2026 at 11:01 PMArgenx discontinues Vyvgart study in Sjögren's disease, shares tumble - Reuters
Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble Reuters
October 8, 2026 at 08:49 PM